The effects of contignasterol (IZP-94,005) on allergen-induced plasma protein exudation in the tracheobronchial airways of sensitized guinea-pigs in vivo.
To examine contignasterol (marine-derived) on allergen-induced plasma exudation in the tracheobronchial airways. English shorthair guinea-pigs actively sensitized to ovalbumin. 21 to 36 days after sensitization, contignasterol, budesonide or nedocromil and then ovalbumin (12 pmol) were superfused onto the tracheal mucosa (i. t.) of anaesthetized animals. Tracer (125I-human serum albumin) was measured in tracheobronchial lavage. Thirty min after administration of contignasterol (100 and 200, but not 0.2 or 2.0 microg/kg), budesonide or nedocromil (200 microg/kg), the ovalbumin response (plasma exudate, microl) was significantly inhibited. The response was also inhibited 5 min after 200 microg/kg nedocromil but not after contignasterol or budesonide. Contignasterol was topically active and showed anti-inflammatory effects in the tracheobronchial airways in that it inhibited allergen-induced plasma protein exudation.